Three priorities to urgently increase access to COVID-19 vaccines
Three priorities to urgently increase access to COVID-19 vaccines Innovative biopharmaceutical companies are at the forefront of the global effort to develop and manufacture safe and effective COVID-19 vaccines and treatments. Today, over 12 billion doses of vaccines have been produced, and more than 60 percent of the world’s population have received at least one…